Latest News about psychedelics
Recent news which mentions psychedelics
Psychedelic Cinema: 10 Trippy Holiday Movies That Warp Reality
November 26, 2023
From Benzinga
Global Psychedelics: Australia's Prescription Guidelines, New Zealand's Meth Addiction Treatment
November 24, 2023
From Benzinga
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
November 24, 2023
From Benzinga
Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice
November 21, 2023
Tickers
CMND
From Benzinga
Three Johns Hopkins Psychedelics Professors Call The Shots On Live Q&A: Knowns, Unknowns, Regulations & Hopes
November 20, 2023
From Benzinga
From Benzinga
Cybin Reports Access To $101M To Sustain Deuterated Psychedelics Programs, Q2 Numbers & 2024 Goals
November 15, 2023
Tickers
CYBN
From Benzinga
GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
November 14, 2023
Tickers
GHRS
From Benzinga
Enveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials
November 14, 2023
Tickers
ENVB
From Benzinga
Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026
November 14, 2023
From Benzinga
GOP Candidate Vivek Ramaswamy Wants Legal Psychedelics And Cannabis For PTSD In New Veterans Plan
November 13, 2023
From Benzinga
Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
November 12, 2023
From Benzinga
Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans?
November 11, 2023
From Benzinga
Cybin Launches Five-Day Units Offering For Up To $64M, Suspends Prior LPC Funding Deal
November 10, 2023
Tickers
CYBN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free